Comparative efficacy of interferon β versus glatiramer acetate for relapsing-remitting multiple sclerosis

Interferon β (INFβ) and glatiramer acetate (GA) are widely used in patients with relapsing–remitting multiple sclerosis (RRMS). However, it is still unclear whether they have different efficacy. We performed a systematic search of head-to-head trials for gaining objective reliable data to compare th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 2015-09, Vol.86 (9), p.1016-1020
Hauptverfasser:	La Mantia, Loredana, Di Pietrantonj, Carlo, Rovaris, Marco, Rigon, Giulio, Frau, Serena, Berardo, Francesco, Gandini, Anna, Longobardi, Anna, Weinstock-Guttman, Bianca, Vaona, Alberto
Format:	Artikel
Sprache:	eng
Schlagworte:	Disease Progression Glatiramer Acetate Humans Interferon-beta - therapeutic use Magnetic Resonance Imaging Multiple Sclerosis, Relapsing-Remitting - drug therapy Multiple Sclerosis, Relapsing-Remitting - pathology Peptides - therapeutic use Randomized Controlled Trials as Topic Treatment Outcome White Matter - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!